Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry

Am J Hematol. 2017 Oct;92(10):E611-E614. doi: 10.1002/ajh.24857. Epub 2017 Aug 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Autografts
  • Bortezomib / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Denmark / epidemiology
  • Dexamethasone / administration & dosage
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / genetics
  • Multiple Myeloma / metabolism
  • Multiple Myeloma / mortality*
  • Multiple Myeloma / therapy*
  • Registries*
  • Stem Cell Transplantation*
  • Survival Rate
  • Thalidomide / administration & dosage

Substances

  • Thalidomide
  • Bortezomib
  • Dexamethasone
  • Cyclophosphamide